Hello Atlas Venture Partner

Welcome to Atlas Ventures Partner Portal. Here you will have access to all the newest information and resources catering to your specific needs and interests. Sign in below for instant access.

Sign In Here

Atlas Venture logo
 
 
 
 

Drive Your Discovery Research

Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Our unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with data and insight you can trust to progress your drug discovery programs.


Charles River Presents: The Innovator’s Series

How do you bring your novel drug to life? Gain insight from entrepreneurs who’ve been in your shoes. In each video of our new series, innovators like you share how they advanced their therapy from concept to clinical and commercial success.

Watch Now


The Benefits of Outsourcing Drug Discovery to an End-to-End CRO

DS-subway-map-webinar-image.jpg

As a preclinical contract research organization (CRO), we offer many benefits when outsourcing drug discovery to us.

Explore The Benefits

Quick Links

Need more information on a specific therapeutic area or technology? Check out these resources…

Oncology

 •   Oncology Translational Tools
 •   Oncology Pharmacology Models
 •   In Vitro Oncology Assays
 •   In Vitro Immuno-Oncology Assays

Neuroscience

 •   Neuroscience Translational Tools
 •   Neuroscience Models & Assays
 •   Neuroscience In Vitro Assays

Platforms and Technologies

 •   Hit Finding eGuide for Hit Identification
 •   Antibody Library Screening Video
 •   Assay Development and Screening

Immunology/Inflammation

 •   Inflammation & Autoimmune Disease Models
 •   In Vitro Immunology Assays

Rare Disease

 •   Amyotrophic Lateral Sclerosis
 •   Huntington’s Disease
 •   Batten’s Disease
 •   Duchenne Muscular Dystrophy

Other

 •   Cardiovascular/Metabolic Disease Models
 •   Musculoskeletal Disease Pharmacology Models
 •   Ocular Translational Tools

Newsletters

Catch up on our latest news collections…

 •   Q2 2020: New Regulations for COVID-19 Vaccine Development

 •   Q1 2020: Expanding Digital Resources To Support You

 •   Q4 2019: See How This Little Girl Changed Drug Development Forever

 •   Q3 2019: A Collaborative Breakthrough for Cardiovascular Patients